Expert Study: Utility of an Automated Bolus Advisor System in Patients with Type 1 Diabetes Treated with Multiple Daily Injections of Insulin—A Crossover Study

Abstract

In this first crossover study comparing the use of an ABA with the standard usual care, the use of an ABA was effective and well accepted. Furthermore, reduction in hypoglycemic events, improvement in adherence and quality of life, and higher treatment satisfaction were observed.

Effects of advanced carbohydrate counting guided by an automated bolus calculator in Type 1 diabetes mellitus (StenoABC): a 12‐month, randomized clinical trial

“…Recently, more small and short-term studies of the same automated bolus calculator have been published [12][13][14].…”

“…In addition, the study confirmed the previous finding of greater treatment satisfaction among users of the automated bolus calculator. Recently, more small and short-term studies of the same automated bolus calculator have been published [12][13][14].…”

No Effect of an Automated Bolus Calculator in Pediatric Patients with Type 1 Diabetes on Multiple Daily Injections: The Expert Kids Study

“…13 Like us, others could not find any differences in variability. 24 Measurement of glucose variability is ideally performed by long-term blinded CGM monitoring; however, in a study lasting several months, it can be quite challenging. We could not demonstrate any change in hypoglycemic or ketoacidosis events due to very few events.…”

Role of Automation/Technology in Day-to-Day Diabetes Care

“…Additionally, improvement in QoL was observed in subjects used ABC (P = 0.007). The current study 9 adds to the existing body of scientific literature about ABC and sets the stage for future studies.…”

“…In this issue of Diabetes Technology & Therapeutics, Gonzalez et al 9 report results from a crossover trial intended to clarify the effect size of ABC in individual patients. They report comprehensive outcomes, including metabolic control, hypoglycemic episodes, and QoL, at the end of the two phases, each lasting 3 months.…”